Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Free Cash Flow (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Free Cash Flow for 6 consecutive years, with -$191.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 71.44% year-over-year to -$191.5 million, compared with a TTM value of -$593.5 million through Dec 2025, up 47.59%, and an annual FY2025 reading of -$844.0 million, down 10.1% over the prior year.
  • Free Cash Flow was -$191.5 million for Q4 2025 at Roivant Sciences, up from -$193.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$123.4 million in Q3 2021 and bottomed at -$675.4 million in Q4 2022.
  • Average Free Cash Flow over 5 years is -$317.8 million, with a median of -$208.4 million recorded in 2025.
  • The sharpest move saw Free Cash Flow plummeted 199.26% in 2021, then surged 71.44% in 2025.
  • Year by year, Free Cash Flow stood at -$541.4 million in 2021, then decreased by 24.74% to -$675.4 million in 2022, then grew by 2.6% to -$657.8 million in 2023, then decreased by 1.95% to -$670.7 million in 2024, then soared by 71.44% to -$191.5 million in 2025.
  • Business Quant data shows Free Cash Flow for ROIV at -$191.5 million in Q4 2025, -$193.5 million in Q3 2025, and -$208.4 million in Q2 2025.